List of chemotherapeutic agents: Difference between revisions
Line 76: | Line 76: | ||
===== Erythrocyte growth factors ===== | ===== Erythrocyte growth factors ===== | ||
===== Granulocyte growth factors ===== | ===== Granulocyte growth factors ===== | ||
*[[ | *[[Filgrastim|Filgrastim (Granix)]] | ||
===== Megakaryocyte growth factors ===== | ===== Megakaryocyte growth factors ===== |
Revision as of 17:52, 11 February 2015
Template:Seealso Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
This is a list of chemotherapeutic agents (also known as cytotoxic agents) that are known to be of use in chemotherapy for cancer. This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision. Each drug is listed once (at present), though it might fall in more than one subsection. A full alphabetical listing is included after the categorical listing.
The agents in this list are often combined into chemotherapy regimens for polychemotherapy (combination chemotherapy). For example, the CHOP regimen consists of cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine (Oncovin), and prednisone.
Besides chemotherapy, medical oncology (pharmacotherapy for cancer) includes several noncytotoxic classes of therapy, such as hormonal therapy and targeted therapy (biologic therapy). Those agents are described in the relevant articles.
Chemotherapeutic Agents by Category
Cytotoxic Chemotherapy
Alkylating agents
Anthracyclines
Antimetabolites
Antimitotic agent
DNA synthesis inhibitors
Microtubule inhibitors
Nitrogen mustards
Nitrosureas
Platinum agents
Proteasome inhibitors
Taxanes
Topoisomerase inhibitors
Vinca alkaloids
Kinase inhibitors
HDAC inhibitors
Endocrine therapy
Antiandrogens
Steroid synthesis inhibitors
Androgen receptor inhibitors
5α-reductase inhibitors
GnRH agonists
GnRH antagonists
Aromatase inhibitors
Selective estrogen receptor modulators
Biologics
Antibody medications
Antibody-drug conjugates
Anti-HER2 medications
IL-6 inhibitors
IL-2 inhibitors
Enzyme Inhibitors
Immunotherapy
Immunomodulatory drugs (IMiDs)
Hematopoietic Growth Factors
Erythrocyte growth factors
Granulocyte growth factors
Megakaryocyte growth factors
Supportive Medications
Chemotherapy protective agents
Antiemetic agents
RANK ligand inhibitors
Miscellaneous
Chemotherapeutic Agents in Alphabetical Order
- Abiraterone acetate (Zytiga)
- Ado-trastuzumab emtansine (Kadcyla)
- Afatinib (Gliotrif)
- Aldesleukin (Proleukin)
- Altretamine (Hexalen)
- Amifostine (Ethyol)
- Anastrozole (Arimidex)
- Arsenic trioxide (Trisenox)
- Asparaginase Erwinia chrysanthemi (Erwinaze)
- Axitinib (Inlyta)
- Azacytidine (Vidaza)
- Belinostat (Beleodaq)
- Bendamustine (Treanda)
- Bevacizumab (Avastin)
- Bexarotene (Targretin)
- Bicalutamide (Casodex)
- Bleomycin (Blenoxane)
- Blinatumomab (Blincyto)
- Bosutinib (Bosulif)
- Brentuximab vedotin (Adcetris)
- Buserelin (Suprefact)
- Busulfan (Myleran-oral)
- Cabazitaxel (Jevtana)
- Cabozantinib (Cometriq)
- Capecitabine (Xeloda)
- Carboplatin (Paraplatin)
- Carfilzomib (Kyprolis)
- Carmustine (BiCNU)
- Ceritinib (Zykadia)
- Cetuximab (Erbitux)
- Chlorambucil (Leukeran)
- Cisplatin (Platinol)
- Crizotinib (Xalkori)
- Dabrafenib (Tafinlar)
- Dasatinib (Sprycel)
- Daunorubicin (Daunoxome)
- Decitabine (Dacogen)
- Degarelix (Firmagon)
- Denileukin diftitox (Ontak)
- Denosumab (Xgeva)
- Dexamethasone (Decadron)
- Dexrazoxane (Zinecard)
- Docetaxel (Taxotere)
- Doxorubicin (Adriamycin, Rubex)
- Enzalutamide (Xtandi)
- Epirubicin (Ellence)
- Eribulin (Halaven)
- Erlotinib (Tarceva)
- Erythropoietin (Epogen, Procrit)
- Estramustine (Emcyt)
- Etoposide (Vespid)
- Everolimus (Afinitor)
- Exemestane (Aromasin)
- Filgrastim (Neupogen)
- Floxuridine (FUDR)
- Fludarabine (Fludara)
- Fluorouracil (Adrucil, Efudex)
- Fluoxymesterone (Halotestin)
- Flutamide (Eulexin)
- Folinic acid (Leucovorin Calcium)
- Fulvestrant (Faslodex)
- Gallium Nitrate (Ganite)
- Gemcitabine (Gemzar)
- Gemtuzumab ozogamicin (Mylotarg)
- Glucarpidase (Voraxaze)
- Goserelin Acetate (Zoladex)
- Hydroxyurea (Hydrea)
- Ibritumomab tiuxetan (Zevalin)
- Ibrutinib (Imbruvica)
- Idarubicin (Idamycin)
- Idelalisib (Zydelig)
- Ifosfamide (Ifex)
- interferon alfa-2b (Intron A)
- Ipilimumab (Yervoy)
- Irinotecan (Camptosar)
- Isotretinoin (Accutane)
- Ixabepilone (Ixempra)
- L-Asparaginase (Elspar)
- Lapatinib (Tykerb)
- Lenalidomide (Revlimid)
- Letrozole (Femara)
- Leuprolide (Lupron)
- Levoleucovorin (Fusilev)
- Lomustine (CeeNU)
- Mechlorethamine (Mustargen)
- Medroxyprogesterone acetate (Provera)
- Megestrol (Megace)
- Melphalan (Alkeran)
- Mercaptopurine (Purinethol)
- Mesna (Mesnex)
- Methotrexate (Mexate, Folex)
- Mitomycin C (Mutamycin)
- Mitotane (Lysodren)
- Mitoxantrone (Novantrone)
- Nelarabine (Arranon)
- Netupitant and palonosetron (Akynzeo)
- Nilotinib (Tasigna)
- Nilutamide (Nilandron)
- Nivolumab (Opdivo)
- Obinutuzumab (Gazyva)
- Octreotide (Octreotide)
- Ofatumumab (Arzerra)
- Olaparib (Lynparza)
- Omacetaxine (Synribo)
- Oprelvekin (Neumega)
- Oxaliplatin (Eloxatin)
- Paclitaxel (Taxol, Onxol)
- Pamidronate (Aredia)
- Panitumumab (Vectibix)
- Pazopanib (Votrient)
- PEG-Asparaginase (Oncaspar)
- Pegfilgrastim (Neulasta)
- Peginterferon alfa-2b (Sylatron)
- Pembrolizumab (Keytruda)
- Pemetrexed (Alimta)
- Pentostatin (Nipent)
- Pertuzumab (Perjeta)
- Plerixafor (Mozobil)
- Pomalidomide (Pomalyst)
- Ponatinib (Iclusig)
- Pralatrexate (Folotyn)
- Prednisone (Deltasone)
- Procarbazine (Matulane)
- Radium-223 chloride (Xofigo)
- Ramucirumab (Cyramza)
- Rasburicase (Elitek)
- Regorafenib (Stivarga)
- Rituximab (Rituxan)
- Romidepsin (Istodax)
- Ruxolitinib (Jakafi)
- Sargramostim (Leukine, Leukomax)
- Siltuximab (Sylvant)
- Sipuleucel-T (Provenge)
- Sorafenib (Nexavar)
- Streptozocin (Zanosar)
- Sunitinib (Sutent)
- Tamoxifen (Nolvadex)
- Tbo-filgrastim (Granix)
- Temozolomide (Temodar)
- Temsirolimus (Torisel)
- Teniposide (Vumon)
- Thalidomide (Thalomid)
- Thioguanine (Tabloid)
- Thiotepa (TESPA)
- Tocilizumab (Actemra)
- Topotecan (Hycamtin)
- Toremifene (Fareston)
- Trametinib (Mekinist)
- Trastuzumab (Herceptin)
- Tretinoin (Vesanoid)
- Vandetanib (Caprelsa)
- Vemurafenib (Zelboraf)
- Vinblastine (Velban, Velsar)
- Vincristine (Oncovin, Vincasar)
- Vincristine liposomal (Marqibo)
- Vinorelbine (Navelbine)
- Vismodegib (Erivedge)
- Ziv-aflibercept (Zaltrap)
- Zoledronic Acid (Zometa)